Business Feb 3, 2015

Novartis Japan unit faces business suspension order

The health ministry will order a business suspension of around 15 days for a Japanese unit of Swiss pharmaceutical maker Novartis AG for not reporting serious side effects of its drugs, sources close to the matter said on Monday. Tokyo-based Novartis Pharma K.K. would be ...